Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo.
about
Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavageMast cell proteoglycansIntegrins are Mechanosensors That Modulate Human Eosinophil Activation.A Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional EffectsRegulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide.Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cellsEndothelial and leukocyte heparan sulfates regulate the development of allergen-induced airway remodeling in a mouse modelDeficiency of endothelial heparan sulfates attenuates allergic airway inflammation.Interference with glycosaminoglycan-chemokine interactions with a probe to alter leukocyte recruitment and inflammation in vivo.Proteoglycans in Normal and Healing Skin.Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.New drugs targeting Th2 lymphocytes in asthma.Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.Altered endochondral ossification in collagen X mouse models leads to impaired immune responsesRole of eotaxin-1 signaling in ovarian cancerChemokine oligomerization in cell signaling and migration.Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infectionNew targets for glycosaminoglycans and glycosaminoglycans as novel targets.Transplantation and inflammation: implications for the modification of chemokine function.The sweet spot: how GAGs help chemokines guide migrating cells.Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System.Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.Chemokines from a Structural Perspective.Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells.Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains
P2860
Q24310228-86D471F8-636D-47D8-B916-8AE16083391CQ27022107-D975418F-9A9C-4AA7-8861-D69639B7C4A4Q27329718-ADDD94B5-DF3E-4EE1-8091-D00159ED0BC6Q27681101-F9B06F6E-2897-4ADF-9F49-08B3A88BFB50Q28072580-A78FCE3C-7ED9-4B8B-9882-FF3DBA269656Q30524305-287CC1A2-864C-4B10-BA00-2DC9E021B353Q33603633-5CF66B60-582A-41C5-962A-D7FA407232D5Q33806763-80BD4CD8-620D-433B-9777-3CFBD2FFC9AEQ33857916-12BA0073-7D77-4DB9-BF96-B0168651C5D6Q34004904-A2EB7FA1-9ECA-40F2-82E5-4C74ECE58B32Q34467680-5E50F007-FAF2-4C52-B5BB-A6EFEFCBEA4DQ35528569-2AAA5BEC-4507-4AF9-BA6A-67F55C519B0BQ36065054-9C68C584-20E9-4A26-9953-C09E049C2102Q36485165-E338553C-ECFA-48C4-B4BC-C5D31AA98801Q36736317-C9AF8C38-EA21-49F1-82E1-233982003395Q37021772-A2D540BB-0C1C-42F5-B149-003BEDAAF330Q37072206-DC12DD4F-0EE1-4C7A-A453-551C4A780448Q37160334-CAFEA35B-30B9-42AB-9958-9DD2F219C080Q37608845-8246F5E8-CA9E-44B3-B2C1-38FD2116760BQ37760881-87B5CA7F-DF30-43CF-9FEC-DE59DE1C9EF5Q38081956-566F47F9-0775-4CF9-93C9-1B01241CCF99Q38218886-07428409-EB59-406E-88E2-34B68D7B26EBQ38678399-DDD96B7B-5D31-4BA8-941F-843D87665228Q38681182-C3BA56BC-CE65-40B4-92DD-012E188228AFQ40232348-7FBDBF33-FE16-411F-A902-E4429E5A5301Q42366882-4F41B69B-E0D6-45D5-AA07-ACC81E85F1F4Q42935186-D3E0EAE2-3C73-4790-8254-816822EABE04Q47154563-EC8D7661-75D3-4715-809F-93FE8FB61D9BQ47327922-C84174A0-7CB4-4698-9D43-FEDDEF117CA6Q47719302-58C39AA2-C69B-4C2C-B081-3CAC989F4399Q48847115-936854B0-F324-46D3-9ED3-F2BF961E5124Q49524220-E6581114-D839-4265-8F18-543DAB207EB1Q58701484-1C1DB929-6BC5-4F4E-9B07-ECBD4238E58D
P2860
Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Eotaxin selectively binds hepa ...... chemotactic activity in vivo.
@en
Eotaxin selectively binds hepa ...... chemotactic activity in vivo.
@nl
type
label
Eotaxin selectively binds hepa ...... chemotactic activity in vivo.
@en
Eotaxin selectively binds hepa ...... chemotactic activity in vivo.
@nl
prefLabel
Eotaxin selectively binds hepa ...... chemotactic activity in vivo.
@en
Eotaxin selectively binds hepa ...... chemotactic activity in vivo.
@nl
P2093
P2860
P356
P1476
Eotaxin selectively binds hepa ...... chemotactic activity in vivo.
@en
P2093
Anna Bezos
Christopher R Parish
Craig Freeman
Julia I Ellyard
Kellie Johnston
Ljubov Simson
P2860
P304
15238-15247
P356
10.1074/JBC.M608046200
P407
P577
2007-03-23T00:00:00Z